Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (1-10 of 528) with videos related to

Pageof 53
Sort By:
Cancer Treatment Reviews|December 1, 1984
MitoxantroneL Nathanson
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1971
Studies with cancer seeking isotopesL Nathanson
Seminars in Oncology|December 1, 1974
Use of BCG in the treatment of human neoplasms: a reviewL Nathanson
Progress in Clinical and Biological Research|January 1, 1983
Immunologic effects of interferons on the cell membraneL Nathanson
National Cancer Institute Monograph|December 1, 1971
In vivo prediction of drug sensitivity with cancer-seeking isotopesL Nathanson
Journal of Cutaneous Pathology|June 1, 1979
Immunotherapy of melanomaL Nathanson
Cancer Chemotherapy Reports|October 1, 1972
Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCGL Nathanson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Clinical prognostic factors in adjuvant melanoma trialL Nathanson
Cancer|March 17, 2001
Risk reduction endpoints should be part of the design of adjuvant therapy clinical trials for patients with melanoma. A commentaryL Nathanson
Cancer|September 1, 1996
Interferon adjuvant therapy of melanomaL Nathanson
Pageof 53

Showing results (1-10 of 528) with videos related to

Sort By:
Pageof 53
Cancer Treatment Reviews|December 1, 1984
MitoxantroneL Nathanson
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|July 1, 1971
Studies with cancer seeking isotopesL Nathanson
Seminars in Oncology|December 1, 1974
Use of BCG in the treatment of human neoplasms: a reviewL Nathanson
Progress in Clinical and Biological Research|January 1, 1983
Immunologic effects of interferons on the cell membraneL Nathanson
National Cancer Institute Monograph|December 1, 1971
In vivo prediction of drug sensitivity with cancer-seeking isotopesL Nathanson
Journal of Cutaneous Pathology|June 1, 1979
Immunotherapy of melanomaL Nathanson
Cancer Chemotherapy Reports|October 1, 1972
Regression of intradermal malignant melanoma after intralesional injection of Mycobacterium bovis strain BCGL Nathanson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Clinical prognostic factors in adjuvant melanoma trialL Nathanson
Cancer|March 17, 2001
Risk reduction endpoints should be part of the design of adjuvant therapy clinical trials for patients with melanoma. A commentaryL Nathanson
Cancer|September 1, 1996
Interferon adjuvant therapy of melanomaL Nathanson
Pageof 53